Safan Bioinformatics

S.A.F.AN. BIOINFORMATICS is a small bioinformatic company based in Torino with the mission of reducing costs and increasing efficiency of bringing new drugs to market Italy. It was born in 2004 after a business plan competition organized by the Politecnico of Turin. Since then it collaborated with most of the italian pharmaceutical companies. In the last years we devolved our time to internal research in order to develop SAFAN-ISP, a new fragment based in-silico screening profiling technology. SAFAN-ISP works now on small molecules SAFAN-ISPSM and on peptides SAFAN-ISPPEPTIDES. It has in silico times and costs but its reliability is similar to an experiment. Our customers can use SAFAN-ISP for: 1. Drug repositioning using the target: disease database 2. Side Effect prediction using target: side effect database 3. Target identification in phenotypic screening outputs. 4- Potential therapeutic indications for natural compounds. In drug repositioning projects rare disease are specifically highlighted. SAFAN-ISP technology can be complemented by the company's structural bioinformatic know how in order to understand the molecular details of ligand binding. S.A.F.AN. BIOINFORMATICS has been part of the H2020 CaSR Biomedicine European Training Network and participated in the Newprot FP7 European project.